Global pandemic

India posts global record of 314,000 daily Covid cases

India's Health Ministry data on Thursday showed 314,835 new infections in the past 24 hours – the most of any country since the pandemic began – as hospitals sent out desperate warnings that patients could die without fresh oxygen supplies.

Relatives and staff carry a dead body of a Covid-19 victim at Nigambodh Ghat Crematorium, on the banks of the Yamuna river in New Delhi in the early hour of April 22, 2021. Foto: Sajjad HUSSAIN / AFP

India posted a global record of almost 315,000 new Covid infections on Thursday as hospitals in New Delhi sent out desperate warnings that patients could die without fresh oxygen supplies.

The country's long-underfunded healthcare system is being stretched to the limit by a devastating second wave of the pandemic blamed on a "double mutant" variant and "super-spreader" mass gatherings.

Health Ministry data on Thursday showed 314,835 new infections in the past 24 hours, the most of any country since the pandemic began, taking total cases to 15.9 million, the world's second highest.

There were 2,074 fatalities, bringing the total death toll to almost 185,000. 

The numbers are however considerably lower on a per capita basis than in many other countries, raising fears that the situation could get a lot worse.

Major private and government-run hospitals in New Delhi have sent out urgent appeals to the central government, calling for more oxygen supplies for hundreds of patients on ventilator support.

On Wednesday, nearly 500 tonnes of oxygen was supplied to Delhi but this fell short of the required 700 tonnes per day.

The megacity's government, run by a different party to Prime Minister Narendra Modi's national administration, has accused neighbouring states governed by Modi's BJP of holding up supplies.

Late Wednesday the Delhi High Court ordered the government to ensure safe passage of oxygen supplies from factories to hospitals across India.

"You beg, borrow and steal but have to provide," the judges said, asking why the government is "not waking up to the gravity of the situation".

"In the last few days there has been a mad scramble for oxygen. One hospital or the other is running short," Delhi chief minister Arvind Kejriwal said Thursday.

"Now oxygen supply is coming... we are trying to ensure every truck carrying oxygen reaches the hospitals," he said, adding that he had requested oxygen be airlifted from the eastern state of Odisha.

'Pants down'

Recent months have seen mass gatherings in India, including millions attending the Kumbh Mela religious festival, political rallies, lavish weddings and cricket matches with spectators.

"The government has been caught with its pants down," call centre executive Navneet Singh, 38, told AFP.

Now, states across India have imposed restrictions, with Delhi in a week-long lockdown, all non-essential shops shut in Maharashtra, and Uttar Pradesh set for a weekend shutdown.

Modi on Thursday still urged voters in West Bengal however "to exercise their franchise" as parts of the eastern state voted.

This is despite West Bengal also reeling from the health crisis, with Kolkata "facing an acute shortage of hospital beds", said Kunar Sarkar, senior vice-chairman of Medica Superspeciality Hospital.

"Beds with oxygen supply are filling fast. Reports are pouring in that at least 100 people are waiting at every hospital in the city," Sarkar told AFP.

Production of key coronavirus drugs slowed or was even halted in early 2021 at some factories and there were delays inviting bids for oxygen generation plants, according to press reports.

Distraught relatives are now being forced to pay exorbitant rates on the black market for medicines and oxygen, while WhatsApp groups are full of desperate pleas for help.

The United States now advises against travel to India, even for those fully vaccinated, while Britain has put India on its "red list". Hong Kong and New Zealand have banned flights.

Australia on Thursday also tightened restrictions on arrivals from India, with Prime Minister Scott Morrison saying returnees from there now made up about 40 percent of Covid cases detected in quarantine.

India's inoculation programme has hit supply hurdles, prompting New Delhi to put the brakes on exports of the AstraZeneca shot, which is manufactured locally by the Serum Institute.

India has administered more than 130 million shots so far and from May 1 all adults will be eligible for a jab.

"I have just one word [for the current situation], which is appalling," college student Ananya Bhatt, 22, told AFP.

"This is all a result of the gross mismanagement by the government... What kind of a country leaves its citizens to suffocate and die in this manner?"

"If the rich are suffering and can't get hospital beds and oxygen, how on Earth will we manage in case we fall sick," said vegetable vendor Mukhtar Ali, 43.

"People are dying because hospitals can't give them oxygen. Who is responsible for their deaths? It is the government, it has failed us." 

 

India's Covid-19 surge and the new variant: what we know

India is battling a record-breaking rise in Covid-19 infections that has overwhelmed hospitals and led to severe bed and oxygen shortages.

A key question is whether a new variant with potentially worrying mutations – B.1.617 – is behind what is currently the world's fastest-growing outbreak. The B.1.617 variant has already appeared elsewhere, including in the United States, Australia, Israel and Singapore. Concern about it has led some countries, including the UK, to slap travel restrictions on India.

Here's what we know.

When did it emerge?

Viruses change all the time and the one that causes Covid-19 has already undergone several thousand mutations – some more concerning than others. India first reported the B.1.617 genome to the global database (GISAID) in October. India's Health Ministry flagged the variant in late March, saying it appeared in 15-20 percent of samples analysed from the worst-hit state Maharashtra. More recently, the figure was 60 percent. The variant has also been detected in 18 other countries as of this month, according to GISAID.

Should we worry?

B.1.617 has been categorised by the World Health Organisation as a "variant of interest." Other variants detected in Brazil, South Africa and the UK have been categorised as "of concern," because they are more transmissible, virulent or might reduce antibody efficacy.

B.1.617 has several mutations, including two notable ones (E484Q and L452R), leading to it sometimes being called the "double mutant." The first notable mutation is similar to another (E484K or sometimes nicknamed "Eek") observed in the South African, Brazilian, and more recently, the UK variants. The "Eek" has been dubbed an "escape mutation" as it helps the virus get past the body's immune system. The other notable mutation was found by a Californian study to be an efficient spreader.

Scientists say more evidence is needed to determine if these mutations make the B.1.617 variant more dangerous.

Is it behind India's spike?

Rakesh Mishra, director of the Hyderabad-based Centre for Cellular and Molecular Biology, is one of the scientists currently analysing the B.1.617 variant. So far, he says it has been "better in terms of spreading compared to other variants." It is not yet known, however, if India's current wave is linked to this variant, or if it is being driven by human behaviour or something else.

Health experts have raised "super spreader" concerns over recent huge religious festivals and political rallies with mostly maskless crowds. Still, several countries are taking no chances with B.1.617. When it banned travel from India this week, the UK specifically cited fears of the new variant. The United States on Wednesday also advised against travel to India, noting that "even fully vaccinated travellers may be at risk for getting and spreading Covid-19 variants."

Are vaccines effective against it?

One of the mutations is related to "Eek", which is suspected of reducing antibody protection from a previous infection or vaccination, said University of Utah evolutionary virology researcher, Stephen Goldstein. Mishra says scientists were testing vaccine efficacy against the variant. Even so, experts say vaccines still offer some protection, particularly from severe cases.

What's next?

Since more variants emerge when there are more infected hosts, Mishra said India needs to get its outbreak under control. Another variant, the B.1.618, recently raised red flags when it became the third-most detected in India.  Goldstein pointed to the UK's success at turning around a recent outbreak despite the presence of a more transmissible variant. "It can be quite onerous, but it can be done," he told AFP. "I think the vaccination campaign certainly helped... but it's the lockdown that enabled them to slow the rise of cases and start to turn the corner."

 

– AFP